3/22/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS FOR USE IN RECOGNIZED CLINICAL TRIALS (IN MEASURED DOSES) (ROW4 NOE-101 2.5 MG BC BKLT LBLD NOE-TSC-201) | 7 | SET | 920 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
3/12/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 4 | SET | 489 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |
3/22/2024 | 300693000000 | PLACEBOAS AND BLINDED (OR DOUBLE-BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (ROW4 NOE-101 1.5MG BC BKLT LBLD NOE-TSC-201) | 5 | SET | 529 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
3/18/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 3 | SET | 443 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |
3/6/2024 | 300693000000 | PLACEBOAS AND BLIND (OR DOUBLE BLIND) CLINICAL TRIAL KITS (IN MEASURED DOSES) FOR USE IN RECOGNIZED CLINICAL TRIALS (KIT WITH 1 VIAL OF NAMILUMAB (KIN-1901) 150MG/ML PLACEBO) | 2 | SET | 407 | N/A | FORTREA TURKEY KLİNİK ARAŞTIRMA LİMİTED ŞİRKETİ |